2004 Annual Meeting | Movement Disorders

Date Sunday 04/25/04

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) William J. Weiner, MD

Topic(s) Movement Disorders

Learning Objectives Upon completion:
Participants should be able to accurately diagnose Parkinson's disease, Huntington's disease, dystonia, tardive dyskinesia and recognize eye movement abnormalities in parkinsonism; understand recent advances in treatment of Parkinson's disease, dystonia, and Huntington's diseases; and appreciate elements of movement disorders which affect quality of life and functional disability.

The American Board of Psychiatry and Neurology has reviewed Movement Disorders and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:35 AM		Psychogenic Movement Disorders: How Do You Know? Mark Hallett, MD, FAAN
09:35 AM - 10:10 AM		Huntington's Disease: Emergent Clinical Features and Implications for Preventive Therapy Ira Shoulson, MD
10:10 AM - 10:40 AM		Tardive Dyskinesia: Is it Disappearing? Daniel Tarsy, MD, FAAN
10:40 AM - 10:55 AM		Break
10:55 AM - 11:25 AM		The Diagnosis of Dystonia Anthony E. Lang, MD, FAAN
11:25 AM - 12:00 PM		Video Presentation Discussion of Diagnosis and Management William J. Weiner, MD
12:00 PM - 01:30 PM		Lunch
01:30 PM - 02:15 PM		Early Parkinson's Disease: What to Do? Stanley Fahn, MD, FAAN
02:15 PM - 03:00 PM		Eye Movement Abnormalities in Parkinsonism Stephen G. Reich, MD, FAAN
03:00 PM - 03:35 PM		Movement Disorders, Disability and Quality of Life Lisa M. Shulman, MD, FAAN
03:35 PM - 03:50 PM		Break
03:50 PM - 04:30 PM		The Movement Disorders in Patient Consultation Howard I. Hurtig, MD
04:30 PM - 05:00 PM		Video Presentation Discussion of Diagnosis and Management of "Unknown" Movement Disorders Patients William J. Weiner, MD

Faculty Disclosures
William J. Weiner, MD	No disclosure on file
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Stanley Fahn, MD, FAAN	Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Mark Hallett, MD, FAAN	Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Daniel Tarsy, MD, FAAN	No disclosure on file
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Ira Shoulson, MD	Dr. Shoulson has received research support from Vaccinex.
Howard I. Hurtig, MD	No disclosure on file

��ɫ��

��ɫ��